EHC - European Haemophilia Consortium / LinkedIn
Dec 16, 2025, 00:32
New on EHCucate: Read about the “History of Replacement Factor Therapies” and More
European Haemophilia Consortium shared a post on LinkedIn:
“From fresh-frozen plasma in the 1950s to today’s extended and ultra-long half-life productsโthe evolution of replacement factor treatments for bleeding disorders showcases over 70 years of remarkable innovation and ingenuity, culminating in personalised therapy.
Want to dive deeper? Explore these new topics on the EHCucate webpage:
- History of Replacement Factor Therapies (RFT)
- Principles of Factor Replacement
- Practical Foundations of RFT
Learn more”
Follow the latest in Hemostasis Today.
-
Sep 3, 2026, 11:21Thrombotic Microangiopathies: From Clinical Syndrome to Molecularly Targeted Therapy
-
Sep 3, 2026, 10:56Elias Othman: Can an Enzyme Involved in Cell Signaling Become a Target for Antithrombotic Drug Discovery?
-
Sep 3, 2026, 10:42Jared Griffard: Hemorrhagic Shock and Component Blood Transfusion
-
Sep 3, 2026, 10:31Alan Nurden: Comparing Antiplatelet and Antithrombin Therapies in Coronary Microcirculation
-
Sep 3, 2026, 08:53Jamieโs Journey Through a Decade with Immune Thrombocytopenia – ITP Support Association
-
Sep 3, 2026, 08:00Beth Meneley: When Transfusion Is Not an Option – HBOT for Exceptional Blood Loss Anemia
-
Sep 3, 2026, 06:27Seyed Mehrab Safdari: Unmasking Factor VII Padua to Prevent Unnecessary Therapy and Thrombotic Risk
-
Sep 3, 2026, 04:09Pedro Perez: Are We Entering a New Era in the Treatment of Intermediate-High-Risk PE?
-
Sep 3, 2026, 04:01Marianne Yee: Supporting Families and Transformative Therapies in Sickle Cell Disease